Table 1.
The table displays the population size and mean ± standard deviation of age at diagnosis, LT4 starting dose, height (H) at puberty onset, heigth gain during puberty, final height (FH), and target height (TH) in the recruited patients classified as etiology and gender. a vs males: p = 0.009
| In situ thyroid | Ectopic gland | Athyreosis | Males | Females | Study cohort | |
|---|---|---|---|---|---|---|
| Number of patients (%) | 44 (20.5 %) | 109 (50.7 %) | 62 (28.8 %) | 63 (29.3 %) | 152 (70.7 %) | 215 (100 %) |
| Age at diagnosis (days) | 25.4 ± 10.1 | 24.1 ± 6.8 | 26.6 ± 15.1 | 24.7 ± 11.7 | 25.2 ± 10.0 | 25.1 ± 10.5 |
| LT4 starting dose (μg/kg/day) | 8.9 ± 2.8 | 8.8 ± 3.0 | 8.6 ± 3.0 | 8.1 ± 2.7 | 9.1 ± 3.0 | 8.8 ± 2.9 |
| H at puberty onset (SDS) | -0.3 ± 1.0 | 0.1 ± 0.9 | -0.2 ± 0.9 | -0.1 ± 0.9 | -0.1 ± 1.0 | -0.1 ± 1.0 |
| Pubertal H gain (SDS) | 0.1 ± 0.7 | -0.2 ± 0.8 | 0.1 ± 0.8 | -0.2 ± 0.8 | 0.0 ± 0.8 | -0.1 ± 0.8 |
| FH (SDS) | -0.2 ± 1.0 | -0.1 ± 1.0 | -0.1 ± 1.1 | -0.3 ± 1.0 | -0.1 ± 1.0 | -0.1 ± 1.0 |
| TH (SDS) | -1.0 ± 1.0 | -0.8 ± 0.9 | -0.7 ± 1.0 | -1.0 ± 0.8 | -0.7 ± 1.0a | -0.8 ± 1.0 |
Data cohort according to aetiology and gender